Galderma Group N (GALD) — Capital Reinvestment Ratio
Galderma Group N (GALD) has a Capital Reinvestment Ratio of 0.08x as of June 2025, meaning it reinvests 0% of its operating cash flow (CHF475.06 Million) in capital expenditures (CHF37.07 Million). See Galderma Group N net asset quality index to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Galderma Group N Capital Reinvestment Ratio (2021–2024)
This chart tracks Galderma Group N's Capital Reinvestment Ratio across 4 annual periods. Check how aggressively does Galderma Group N reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Galderma Group N (2021–2024)
Year-by-year Capital Reinvestment Ratio for Galderma Group N from 2021 to 2024. For live market cap and broader valuation context, see market cap of Galderma Group N.
| Year | Reinvestment Ratio | Operating CF (CHF) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.64x | CHF429.77 Million | CHF275.00 Million | ▼ -6.8% |
| 2023 | 0.69x | CHF148.64 Million | CHF102.02 Million | ▼ -52.1% |
| 2022 | 1.43x | CHF106.30 Million | CHF152.33 Million | ▲ +119.1% |
| 2021 | 0.65x | CHF178.92 Million | CHF117.03 Million | — |